Rhodes Jason P
5 of 16 shown
The 5 most recent of 16 visible filings, newest first.
- Dyne Therapeutics, Inc. Director$8,061,625Open-market sale
- Dyne Therapeutics, Inc. Director$11,959,425Open-market sale
- Dyne Therapeutics, Inc. Director$33,991,850Open-market sale
- Dyne Therapeutics, Inc. Director$1,667,447Open-market sale
- Dyne Therapeutics, Inc. Director$2,473,673Open-market sale